1.Investigation of the relationship between G395R mutation of human sodium/iodide symporter and congenital hypothyroidism
Shengli YAN ; Zhen ZHAO ; Ping FU
Chinese Journal of Endocrinology and Metabolism 1985;0(02):-
The G395R mutation of human sodium/iodide symporter gene was investigated by PCR-RFLP in 52 children with congenital hypothyroidism and 106 health children. The result suggested that G395R mutation may not be the main cause of congenital hypothyroidism in Qingdao.
2.Antithrombotic Effect of Orientoside
Xiaochun FU ; Xiaogen WANG ; Zhen YAN
China Pharmacy 2005;0(17):-
OBJECTIVE:To study the antithrombotic effect of orientoside.METHODS:The effects of prophylactic oriento_side on the clotting time in vitro and the systemic clots dissolution of mice,the plasma prothrombin time(PT),the kaolin partial thromboplastin time(KPTT),the thrombin time(TT),and the platelet aggregation induced by ADP and the euglobulin lysis time (ELT)in rabbits were studied.RESULTS:As compared with the normal saline group,orientoside(1,2,and 4mg/kg)signi_ficantly prolonged the clotting time of mice in vitro,yet which had no significant influence on the systemic clots dissolution of mice;while orientoside(0.625,1.25 and 2.5 mg/kg)significantly prolonged the PT,KPTT and TT of rabbits,and significantly inhibited platelet aggregation of rabbits induced by ADP,yet which had no significant influence on the ELT of the rabbits.CONCLUSION:Orientoside can significantly inhibit the formation of thrombus.
3.Relationship between T354P mutation of the human sodium/iodine symporter and congenital hypothyroidism.
Zhen ZHAO ; Sheng-li YAN ; Ping FU
Chinese Journal of Pediatrics 2004;42(6):456-457
Case-Control Studies
;
Child, Preschool
;
Congenital Hypothyroidism
;
DNA
;
genetics
;
Female
;
Humans
;
Hypothyroidism
;
genetics
;
Infant
;
Iodine
;
metabolism
;
Male
;
Mutation
;
Polymerase Chain Reaction
;
Sodium
;
metabolism
;
Symporters
;
genetics
5.The Progress of Food and Medical on Values of Puff-balls
Hui-Zhen ZHAO ; Yan-Yan XU ; Xiao-Yan FU ; Li FAN ;
Microbiology 1992;0(02):-
Puff-balls is a very distinctive macro-fungi in biodiversity.It is used to be a styptic,repellent and alexipharmic in China.This paper simply summarizes the puffball′s taxonomy in the fungi and its distribution in the world; and emphasizes on its composition,food uses,medical uses,herbalism studies and progress of researches on clinical applications.And it points out the patent prospect and current problems of the puff-balls.
6.Research and development of Fructus Gardeniae.
Hui-Yan NI ; Zhao-Hui ZHANG ; Hai-Zhen FU
China Journal of Chinese Materia Medica 2006;31(7):538-541
Survey on research and development of Fructus Gardeniae in the recent 10 years. Gardenia yellow has been used for food colorent, medicine, feedingstuff and cosmetic. Garnedia blue has been used for developing another pigment with red and yellow. Fructus Gardeniae has been used in digestive system for cholecyst constracting and gall-stone eliminating, for declining peroxide on SAP mouse and increasing immune ability, for protecting liver against cancel, anti-acetylcholinic restraining on stomach enginery, in cardiovascular system it has been used for centrally anti-hypertension, preventing atheroma and thrombus, also Fructus Gardeniae has been used for anti-inflammation, treating parenchyma injure etc. Geniposide used for increasing production in agriculture has wider perspect.
Analgesics
;
pharmacology
;
Animals
;
Anti-Inflammatory Agents, Non-Steroidal
;
pharmacology
;
Antihypertensive Agents
;
pharmacology
;
Bile
;
secretion
;
Drugs, Chinese Herbal
;
isolation & purification
;
pharmacology
;
Food Coloring Agents
;
toxicity
;
Fruit
;
chemistry
;
Gardenia
;
chemistry
;
toxicity
;
Gastric Acid
;
secretion
;
Humans
;
Lipid Peroxidation
;
drug effects
;
Plant Extracts
;
isolation & purification
;
toxicity
;
Plants, Medicinal
;
chemistry
7.Discussion on the veno-venous bypass in autologous liver transplantation
Wei WANG ; Qifa YE ; Xiaoli FAN ; Yan XIONG ; Zhen FU ; Yanfeng WANG
Chinese Journal of Hepatobiliary Surgery 2015;21(9):641-644
Liver transplantation is the main treatment for end-stage liver diseases and liver tumor.To solve the problem of the insufficient donor liver,autologous liver transplantation (ALT) is becoming widely acknowledged,which could serve as a complementary technique for treating unresectable liver space-occupying lesions in routine operation.However,compared with allogeneic liver transplantation,the long anhepatic phase during ALT may influence the outcome of such patients.Veno-venous bypass (VVB) as a technology which can maintain the stability of hemodynamics and internal environment in the anhepatic phase is routinely used in ALT.In this paper,the application of VVB in the ALT was mainly discussed.
8.Advance of Functional Magnetic Resonance Imaging in Motor Function of Hand in Patients with Stroke (review)
Zhen FU ; Nan HU ; Cuihuan PAN ; Ping MIAO ; Rui YU ; Yan CHEN
Chinese Journal of Rehabilitation Theory and Practice 2015;(11):1277-1281
Functional magnetic resonance imaging (fMRI), a newly developing technique, contains function, anatomy and image, which makes the real-time, dynamic and non-invasive measurement of the functional brain imaging availability. This paper summarized the characteristics of fMRI in health and stroke populations, introduced the advances of fMRI in neuroplasticity, rehabilitation assessment and prognosis in hand movement dysfunction in patients with stroke, and discussed the difficulty fMRI faced in rehabilitation assessment and the further researches.
9.Executive dysfunction in different subtypes of vascular cognitive impairment
Qihao GUO ; Lilin JIN ; Jianhui FU ; Yan ZHOU ; Qianhua ZHAO ; Zhen HONG
Chinese Journal of Neurology 2009;42(5):314-318
Objective To investigate the executive function features of different subtypes of vascular cognitive impairment (VCI). Methods Sixty-four subjects with subcortical ischaemic vascular disease (SIVD) presumed by medical history and neuroimaging (cranial MRI) were recruited. The clinical and neuropsychological features of the 4 groups were compared: cognitive normal control (n=25), simple executive impairment of VCI-ND (s-VCI-ND, n=16), multi-domain impairment of VCI-ND (m-VCI-ND, n=26) and vascular dementia (VaD) patients (n=22). All participants underwent neuropsychological tests covering global cognitive function, executive function, memory function, language function and visual spatial skills. The executive tests included 15 independent subtest reflect set shifting, inhibition of prepotent responses, working memory, concept formation and fluency. Results Tower of Hanoi, self ordered pointing test and paced auditory serial addition test were not suitable for identification of VCI-ND because their finish rates were less 50%. Performance of trail making test (216.5±69.3 vs 137.4±37.9), Stroop color words test (115.4±30.1 vs 72.9±17.5), California cards sorting test-Chinese version (1.9±1.4 vs 2.7±1.2)and animal category fluency test(14.2±2.3 vs 17.7±4.4) had significant difference between s-VCI-ND group and cognitive normal control group (t=4.73, 5.72, 2.04 and 3.53, all P<0.05) and these tests were applicable and sensitive assessment tools in all executive tests. Time-consuming index showed more sensitivity than correct index in executive function. Neuropsychological deficits of m-VCI-ND patients showed lower than that of s-VCI-ND group and better than that of VaD patients. It was likely that the m-VCI-ND was a transition state between normal aging and VaD. Conclusion Executive dysfunction of VCI caused by SIVD is short of specificity. Some tests may appear earlier in screening of VCI-ND.
10.Effect of low-dose glucocorticoid on corticosteroid insufficient patients with acute exacerbation of chronic obstructive pulmonary disease
Wei-Ping SUN ; Guang-Xiong YUAN ; Yan-Juan HU ; Li-Zhen LIAO ; Lin FU
World Journal of Emergency Medicine 2015;6(1):34-39
BACKGROUND: This study aimed to investigate the prevalence rate of critical illness-related corticosteroid insufficiency (CIRCI) and the effect of low-dose glucocorticoid on prognosis of CIRCI in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). METHODS: Since January 2010 to December 2012, 385 patients, who met the criteria of AECOPD, were enrolled in the Intensive Care Unit (ICU) of the First People's Hospital and Municipal Central Hospital of Xiangtan City. The AECOPD patients complicated with CIRCI screened by an adrenalcorticotrophic hormone test within 12 hours after admission to ICU were divided into a treatment group (n=32) and a control group (n=31) for a prospective, randomized and controlled clinical trial. Hydrocortisone (150 mg/d) or normal saline was injected intravenously for 7 days. The patients were followed up for 28 days after injection. The endpoint included 28-day survival time, non-shock time, ICU stay and the period of non-mechanical ventilation. The markers of inflammation C-reactive protein, tumor necrosis factor-α, interleukin 6 and procalcitonin were measured at baseline and 7 days after treatment. The variables were analyzed by Student's t test, the non-parametric statistical test, the Chi-square test or the Kaplan-Meier method with SPSS18.0 statistic software. A P value <0.05 was considered statistically significant. RESULTS: Totally 63 patients were diagnosed with CIRCI by an adrenalcorticotrophic hormone test and the prevalence rate was 16.4%. The shock rate of the AECOPD patients complicated with CIRCI was higher than that of the AECOPD patients without CIRCI (23.8% vs. 8.7%, P<0.01). Kaplan-Meier analysis revealed that the 28-day survival time of the treatment group was obviously longer than that of the control group (P<0.05). Compared with the control group, shock-free days within 28 days was longer in the treatment group (18.2±9.5 vs. 25.8±4.1, P<0.05). Treatment with low-dose glucocorticoid obviously decreased the markers of infection and inflammation (P<0.01), such as C-reactive protein (13.2±5.5 mg/L vs. 8.3±3.1 mg/L for the control group; 13.5±5.9 mg/L vs. 5.1±2.3 mg/L for the treatment group), tumor necrosis factor-α (26.1±16.2 g/L vs. 17.5±11.7 g/L for the control group; 25.0±14.8 g/L vs. 10.4±7.8 g/L for the treatment group) and procalcitonin (3.88 g/L vs. 2.03 g/L for the control group; 3.77 g/L vs. 1.26 g/L for the treatment group). Furthermore, the markers in the treatment group decreased more obviously than those in the control group (P<0.01). CONCLUSION: The prevalence rate of CIRCI was higher in the patients with AECOPD in the department of critical medicine, and low-dose glucocorticoid treatment for one week reduced the 28-day mortality, shock time and markers of infection and inflammation.